A Rare Case Presentation of Vitiligo Associated With Atezolizumab

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies used in the treatment of solid and hematologic malignancies. Immune checkpoint inhibitors target the T-cell deactivation system via the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) receptor, programmed cell death protein 1 (PD-1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwanwene, Kemnasom, Abdallah, Mahmoud, Pacioles, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909063/
https://www.ncbi.nlm.nih.gov/pubmed/36748760
http://dx.doi.org/10.1177/23247096231154640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909063/
https://www.ncbi.nlm.nih.gov/pubmed/36748760
http://dx.doi.org/10.1177/23247096231154640

Ejemplares similares